Biotech News

MIMEDX Announces Restructuring and Cost Reduction Initiative

MiMedx (MDXG)MiMedx2026-06-25 13:46 ESTCompany update

Company Expects to Realize Annualized Savings of Approximately $40 Million MARIETTA, Ga., April 16, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced a series of cost reduction initiatives intended to prioritize growth opportunities, streamline

Open original release

Related news

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX Announces Launch of G4Derm® Plus

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX Announces Launch of CHORIOFIX™

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX to Sponsor Leading Advanced Wound Care Conferences

MDXGMiMedx2026-06-25 13:46 EST

MIMEDX Announces First Quarter 2026 Operating & Financial Results

View all latest news

MiMedx

MiMedx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

MDXGMiMedx2026-06-26 10:40 EST

MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference

MDXGMiMedx2026-06-26 10:40 EST

MIMEDX Announces Launch of G4Derm® Plus

MDXGMiMedx2026-06-26 10:40 EST

MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®

MDXGMiMedx2026-06-26 10:40 EST

MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products

MDXGMiMedx2026-06-26 10:40 EST

MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States